Ocugen, Inc. revenue breakdown overview

Ocugen, Inc. revenue for the last year amounted to 4.05 M USD, the most of which — 4.05 M USD — came from its highest performing source at the moment, Novel Gene and Cell Therapies, Biologics and Vaccines, the year earlier bringing 6.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ocugen, Inc. 4.05 M USD, and the year before that — 6.04 M USD.